Using computational modeling to drive the development of targeted therapeutics.
UB Nielsen, B Schoeberl - Idrugs: the Investigational Drugs Journal, 2005 - europepmc.org
UB Nielsen, B Schoeberl
Idrugs: the Investigational Drugs Journal, 2005•europepmc.orgComputational biology is impacting drug design and has the potential to revolutionize the
drug development process. Here, we describe how data-driven computational models can
optimize the design of targeted therapeutics to yield improved safety and efficacy. We
propose that, in the future, this approach will improve drug discovery, clinical development,
diagnosis and treatment.
drug development process. Here, we describe how data-driven computational models can
optimize the design of targeted therapeutics to yield improved safety and efficacy. We
propose that, in the future, this approach will improve drug discovery, clinical development,
diagnosis and treatment.
Computational biology is impacting drug design and has the potential to revolutionize the drug development process. Here, we describe how data-driven computational models can optimize the design of targeted therapeutics to yield improved safety and efficacy. We propose that, in the future, this approach will improve drug discovery, clinical development, diagnosis and treatment.
europepmc.org